Cargando…

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia

Recurrent chromosomal abnormalities and gene mutations detected at the time of diagnosis of acute myeloid leukemia (AML) are associated with particular disease features, treatment response and survival of AML patients, and are used to denote specific disease entities in the World Health Organization...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eisfeld, A-K, Mrózek, K, Kohlschmidt, J, Nicolet, D, Orwick, S, Walker, C J, Kroll, K W, Blachly, J S, Carroll, A J, Kolitz, J E, Powell, B L, Wang, E S, Stone, R M, de la Chapelle, A, Byrd, J C, Bloomfield, C D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628133/ https://www.ncbi.nlm.nih.gov/pubmed/28321123 http://dx.doi.org/10.1038/leu.2017.86

Ejemplares similares

Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
por: Eisfeld, Ann-Kathrin, et al.
Publicado: (2018)

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
por: Eisfeld, Ann-Kathrin, et al.
Publicado: (2018)

Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically
por: Mrózek, Krzysztof, et al.
Publicado: (2019)

Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia
por: Papaioannou, Dimitrios, et al.
Publicado: (2017)

Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
por: Fobare, Sydney, et al.
Publicado: (2022)

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study
por: Bhatnagar, Bhavana, et al.
Publicado: (2023)

Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement
por: Bill, Marius, et al.
Publicado: (2021)

Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
por: Mrózek, Krzysztof, et al.
Publicado: (2023)

Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia
por: Papaioannou, Dimitrios, et al.
Publicado: (2021)

No evidence for microsatellite instability in acute myeloid leukemia
por: Walker, Christopher J., et al.
Publicado: (2017)

A precision medicine classification for treatment of acute myeloid leukemia in older patients
por: Mims, Alice S., et al.
Publicado: (2021)

Association of social deprivation with survival in younger adult patients with AML: an Alliance study
por: Rebechi, Melanie, et al.
Publicado: (2023)

Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia
por: Bill, Marius, et al.
Publicado: (2020)

Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA
por: Walker, Christopher J., et al.
Publicado: (2018)

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
por: Niederwieser, Christian, et al.
Publicado: (2014)

MuCor: mutation aggregation and correlation
por: Kroll, Karl W., et al.
Publicado: (2016)

High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML
por: Larkin, Karilyn T., et al.
Publicado: (2022)

Controlled variable selection in Weibull mixture cure models for high‐dimensional data
por: Fu, Han, et al.
Publicado: (2022)

PyOncoPrint: a python package for plotting OncoPrints
por: Park, Jeongbin, et al.
Publicado: (2023)

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
por: Whitman, Susan P., et al.
Publicado: (2013)

Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT 3‐ITD AML
por: Buelow, Daelynn R., et al.
Publicado: (2019)

Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia
por: Epstein-Peterson, Zachary D., et al.
Publicado: (2022)

Characterization and mitigation of fragmentation enzyme-induced dual stranded artifacts
por: Gregory, Thomas, et al.
Publicado: (2020)

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B study (CALGB 10503)
por: Blum, William, et al.
Publicado: (2016)

Cytogenetic analysis of meningiomas.
por: Cho, J. H., et al.
Publicado: (1992)

Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes
por: Rathnayake, A. J. I. S., et al.
Publicado: (2016)

Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes
por: Ferraro, Francesca, et al.
Publicado: (2021)

Cytogenetic Profile of de novo Acute Myeloid Leukemia Patients in Malaysia
por: Meng, Chin Yuet, et al.
Publicado: (2013)

Cytogenetic and Array-CGH Characterization of a Complex de novo Rearrangement Involving Duplication and Deletion of 9p and Clinical Findings in a 4-Month-Old Female
por: Hulick, P. J., et al.
Publicado: (2010)

Cytogenetic abnormalities in Langerhans cell histiocytosis.
por: Betts, D. R., et al.
Publicado: (1998)

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
por: Tsui, Sze P., et al.
Publicado: (2020)

Integration of cytogenetic landmarks into the draft sequence of the human genome
por: BAC Resource Consortium, The, et al.
Publicado: (2001)

Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia
por: Brinton, Lindsey T., et al.
Publicado: (2020)

P986: CYTOGENETIC DIAGNOSIS WITH NEXT-GENERATION CYTOGENETICS BY OPTICAL GENOME MAPPING IN PATIENTS WITH MYELOFIBROSIS.
por: Díaz González, Á., et al.
Publicado: (2022)

Two molecular cytogenetic views of breast cancer
por: Gray, J, et al.
Publicado: (2000)

Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes
por: Chaubey, Rekha, et al.
Publicado: (2011)

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
por: Ngankeu, Apollinaire, et al.
Publicado: (2017)

Molecular cytogenetic analysis of breast cancer cell lines
por: Davidson, J M, et al.
Publicado: (2000)

A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485
por: Mims, Alice S., et al.
Publicado: (2018)

Presence but not number of secondary type mutations influences outcome in de novo AML without MDS‐associated or recurring cytogenetic abnormalities
por: Weinberg, Olga K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_02ljubr45vfitvbnf0i7eq6gjd